The impact of neurological performance and volumetrics on overall survival in brain metastasis in colorectal cancer: a retrospective single-center case series

• Published in: BMC cancer Vol. 22; no. 1; p. 336
• Main Authors: Sander, Caroline, Frydrychowicz, Clara, Prasse, Gordian, Taubenheim, Sabine, Arlt, Felix, Meixensberger, Jürgen, Fehrenbach, Michael Karl
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 28.03.2022; BioMed Central; BMC
• Subjects: Brain cancer; Brain metastasis; Cancer; Cancer therapies; Care and treatment; Colorectal cancer; Colorectal carcinoma; Diagnosis; Liver; Localization; Magnetic resonance imaging; Medical prognosis; Medical research; Metastases; Metastasis; Multivariate analysis; Neurologic manifestations of general diseases; Neurologic performance; Neurosurgery; Patient outcomes; Patients; Prevention; Prognosis; Prognostic factors; Radiation therapy; Radiotherapy; Risk factors; Software; Statistical analysis; Surgery; Survival; Tumors; Volumetrics; Germany; United States > US; Neurologic performance; Radiotherapy; Volumetrics; Brain metastasis; Prognostic factors; Colorectal cancer
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-022-09435-1

Brain metastasis (BM) of colorectal cancer is a disease with a poor prognosis of only a few months survival. However, it is difficult to estimate the individual prognosis of each patient due to the lack of definitive prognosis parameters. The number of metastases and the Karnofsky performance score are known predictors for survival. We investigated whether or not the neurological performance score and the tumor volumetrics are equally suitable predictors for survival. All patients with histologically diagnosed BM linked to colorectal cancer between 2012 and March 2020 were reviewed. The Medical Research Council Neurological Performance Score was used to quantify neurological performance. Univariate analysis with Kaplan-Meier estimate and log-rank test was performed. Survival prediction and multivariate analysis were performed employing Cox proportional hazard regression. Twenty-five patients were included in our analysis with an overall survival of 4.9 months after surgery of the BM. Survival decreased in the univariate analysis with increasing postoperative neurological performance score, low Karnofsky performance score, absence of radiation therapy and radiation therapy modality. The neurological performance score is a reliable scoring parameter for estimating the prognostic course analogous to the Karnofsky performance score. Neither preoperative nor post resection residual tumor volume had any impact on overall survival in our small cohort. Our data suggest that the postoperative neurological performance is a valuable prognostic factor for colorectal cancer patients with BM. Tumor volumetrics show no correlation to survival. Further investigations with a larger number of cases are mandatory.